Skip to content
10-Q

Quarterly Report

CHINA PHARMACEUTICALS INC

0001013762-12-001203

← back to feed
Filed
May 21, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2012 · Mar 31, 2012 75.24M sh
Shares Diluted Q1 2012 · Mar 31, 2011 70.67M sh
Operating Cash Flow Q1 2012 · Mar 31, 2012 $112.14K
Operating Cash Flow Q1 2012 · Mar 31, 2011 $4.71M
Cash And Equivalents Q1 2012 · Mar 31, 2012 $16.73M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $16.95M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $9.51M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $4.73M
Stockholders Equity Q1 2012 · Mar 31, 2012 $48.43M
Stockholders Equity Q1 2012 · Dec 31, 2011 $48.78M
Current Liabilities Q1 2012 · Mar 31, 2012 $2.79M
Current Liabilities Q1 2012 · Dec 31, 2011 $2.35M
Current Assets Q1 2012 · Mar 31, 2012 $22.88M
Current Assets Q1 2012 · Dec 31, 2011 $22.85M
Total Assets Q1 2012 · Mar 31, 2012 $51.22M
Total Assets Q1 2012 · Dec 31, 2011 $51.13M
Eps Diluted Q1 2012 · Mar 31, 2012 −$0.01
Eps Diluted Q1 2012 · Mar 31, 2011 $0.04
Eps Basic Q1 2012 · Mar 31, 2012 −$0.01
Eps Basic Q1 2012 · Mar 31, 2011 $0.04
Sga Expense Q1 2012 · Mar 31, 2012 $1.22M
Sga Expense Q1 2012 · Mar 31, 2011 $1.26M
Net Income Q1 2012 · Mar 31, 2012 −$401.31K
Net Income Q1 2012 · Mar 31, 2011 $2.89M
Operating Income Q1 2012 · Mar 31, 2012 −$407.9K
Operating Income Q1 2012 · Mar 31, 2011 $3.34M
Gross Profit Q1 2012 · Mar 31, 2012 $767.36K
Gross Profit Q1 2012 · Mar 31, 2011 $4.32M
Cost Of Revenue Q1 2012 · Mar 31, 2012 $812.87K
Cost Of Revenue Q1 2012 · Mar 31, 2011 $3.37M